FCM
MEDP icon

Fieldview Capital Management’s Medpace MEDP Stock Holding History

Fieldview Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,264
Closed -$710K – 639
2025
Q4 		$710K Sell
1,264
-748
-37% -$425K 0.12% 224
2025
Q3 		$1.03M Sell
2,012
-7,572
-79% -$3.31M 0.17% 178
2025
Q2 		$3.01M Sell
9,584
-6,254
-39% -$1.88M 0.45% 84
2025
Q1 		$4.83M Buy
15,838
+2,772
+21% +$932K 0.68% 30
2024
Q4 		$4.34M Buy
+13,066
New +$4.43M 0.67% 37

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fieldview Capital Management's MEDP Position: Q1 2026 in Review

Fieldview Capital Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 1,264 shares — an estimated $710K sold.

Fieldview Capital Management first reported a position in MEDP in Q4 2024 and held it in 5 quarters. The position peaked at $4.83M in Q1 2025. 732 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Fieldview Capital Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 1,264 Medpace shares in Q1 2026, an estimated $710K.
  • Fieldview Capital Management first reported a position in Medpace in Q4 2024 and held it in 5 quarters.
  • Fieldview Capital Management's Medpace position peaked at $4.83M in Q1 2025.
  • 732 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Fieldview Capital Management's 13F filing for Q1 2026, filed 14 May 2026.